According to I-Mab Biopharma's latest financial reports the company's current revenue (TTM) is €33.22 M. In 2022 the company made a revenue of -€29.35 M a decrease over the revenue in the year 2021 that were of €12.62 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.